Financings of the Fortnight Wants To Spin You Right 'Round, And Out
This article was originally published in The Pink Sheet Daily
Executive Summary
Recently public Akebia is just one of the many biotechs making a case for spin-outs driven by economic needs. Also, Sangamo, Ataxion, Galmed and SAGE tap the financing pool.